Warning: TCI has been made aware of false correspondence being circulated via e-mail. Such scam may seek to obtain personal electronic details from the recipients and/or in isolated cases payment information from such correspondence. TCI wishes to warn its customers about the possibility of such fraudulent activities. Still be ensured that TCI does everything to protect its customers. In case of doubt please do not hesitate to contact us.
CAS RN: | Product Number: A3342
Anti-Perlecan Monoclonal Antibody (HK-102)
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Volume/Quantity : 0.1 mg
Product Form : Purified rat monoclonal antibody/IgG2a, κ-chain
Buffer : Phosphate buffered saline (PBS)
Preparation : The antibody is purified from culture supernatant.
Preservative : 0.05% sodium azide
Stabilizer : None
Immunogen : Heparan sulfate proteoglycans (HSPGs) extracted from Engelbreth-Holm-Swarm (EHS) mouse tumor
Specificity : The monoclonal antibody recognizes the core protein moiety of low density-HSPG (Perlecan) of mouse.
Clone Name : HK-102
Immunohistochemistry, Western blot.
Store at －20 ºC to －80 ºC (preferably at －80 ºC). It is not recommended storing at 4 ºC. Avoid repeated freezing and thawing.
|Physical State (20 deg.C)||Liquid|
|Condition to Avoid||Heat Sensitive|
|Appearance||Colorless to Almost colorless clear liquid|
|Titer(ELISA)||to pass test(ELISA)|
- Basement membrane proteoglycan in various tissues: characterization using monoclonal antibodies to the Engelbreth-Holm-Swarm mouse tumor low density heparan sulfate proteoglycan.
- The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.